← Browse by Condition
Medical Condition
myelofibrosis
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1
NCT05875805
Recruiting
A Telehealth Advance Care Planning Intervention
Enrollment
207 pts
Location
United States
Sponsor
University of Rochester
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT05805605 Phase 2
Recruiting
Allo HSCT Using RIC and PTCy for Hematological Diseases
Enrollment
56 pts
Location
United States
Sponsor
Masonic Cancer Center, Univers...
NCT02934477
Recruiting
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
Enrollment
650 pts
Location
United States
Sponsor
Center for International Blood...
NCT05371964 Phase 1
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
Enrollment
36 pts
Location
United States
Sponsor
Geron Corporation
NCT04655118 Phase 2
Recruiting
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Enrollment
121 pts
Location
United States, Austr...
Sponsor
Telios Pharma, Inc.
NCT05037760 Phase 2
Recruiting
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Enrollment
135 pts
Location
Australia, Brazil, F...
Sponsor
Takeda